Wealthcreatures.com
Jubilant Ingervia Ltd Quick Trade Cmp - 470 Add at cmp & on Dips till 440 Test Levels # 500/525/550/600+ TF - 1 To 2 Month S/L - 414 on closing basis or As per Risk
Jubilant ingervia
Buying opportunity on all dips
Lows - 464
Buying opportunity on all dips
Lows - 464
Wealthcreatures.com
LINCOLN PHARMA CMP - 314 Support @ 312/300 Getting Ready For 2nd Round of upmove very soon Results on 25th May
Lincoln pharma
Again Available @ 315
Support@ 312/310
Results Bet
Play As per Risk for trading
Again Available @ 315
Support@ 312/310
Results Bet
Play As per Risk for trading
Wealthcreatures.com
Lincoln pharma Again Available @ 315 Support@ 312/310 Results Bet Play As per Risk for trading
Lincoln pharma
306
One can add now for Delivery 3 - 6 - 12 months
Strong Fundamentals
Debt free company
LINCOLN PHARMA: CO PLANS TO ENTER EU MARKETS IN FY22 WITH DERMATOLOGY, GASTRO & PAIN MANAGEMENT PRODUCTS
306
One can add now for Delivery 3 - 6 - 12 months
Strong Fundamentals
Debt free company
LINCOLN PHARMA: CO PLANS TO ENTER EU MARKETS IN FY22 WITH DERMATOLOGY, GASTRO & PAIN MANAGEMENT PRODUCTS
Wealthcreatures.com
https://wealthcreatures.com/2020/04/16/power-mech-projects-can-it-again-powerup/ POWER MECH DEEPLY UNDERVALUED RE RATING CANDIDATE VERY 🔜🔜 VALUE BUYING CAN EMERGE
POWER MECH
6% 💚
New 52wk High # 638
Getting Ready For paisa Double 🔜
6% 💚
New 52wk High # 638
Getting Ready For paisa Double 🔜
#Thought
You can't be a successful trader if you can't control your emotions when price goes against you.
#Wealthcreatures.com
You can't be a successful trader if you can't control your emotions when price goes against you.
#Wealthcreatures.com
CAMS LTD
Very Strong Numbers
Update Q4FY21 & FY21 Numbers
QoQ ( Q4FY21 VS Q3FY21 )
REVENUE: 204 cr vs 192 cr
( 6% up)
PBT: 81 cr vs 76 cr (7% up)
EPS: 12.32 vs 11.56
YoY ( Q4FY21 VS Q4FY20)
REVENUE: 204 cr vs 178 cr ( 15% up)
PBT: 81 cr vs 67 cr (21% up)
EPS: 12.32 vs 8.83
FY21 VS FY20
REVENUE : 735 cr vs 721 cr ( 2% up)
PBT : 274 cr vs 247 cr ( 11% up)
EPS: 42.08 vs 35.24
OCF: 262cr VS 199cr
Dividend Rs.11.84 per share
Very Strong Numbers
Update Q4FY21 & FY21 Numbers
QoQ ( Q4FY21 VS Q3FY21 )
REVENUE: 204 cr vs 192 cr
( 6% up)
PBT: 81 cr vs 76 cr (7% up)
EPS: 12.32 vs 11.56
YoY ( Q4FY21 VS Q4FY20)
REVENUE: 204 cr vs 178 cr ( 15% up)
PBT: 81 cr vs 67 cr (21% up)
EPS: 12.32 vs 8.83
FY21 VS FY20
REVENUE : 735 cr vs 721 cr ( 2% up)
PBT : 274 cr vs 247 cr ( 11% up)
EPS: 42.08 vs 35.24
OCF: 262cr VS 199cr
Dividend Rs.11.84 per share
BAJAJ ELECTRICAL
Q4FY21 & FY21 Numbers
Numbers are ok.Not that Good
QoQ ( Q4FY21 VS Q3FY21 )
REVENUE: 1289 cr vs 1522 cr ( 15% down)
PBT: 75 cr vs 134 cr(79% down)
EPS: 5 vs 8.59
YoY ( Q4FY21 VS Q4FY20)
REVENUE: 1289 cr vs 1318 cr ( 2.2% down)
PBT: 75 cr vs (-1.38) cr(5535% Up)
EPS: 5 vs 0.08
FY21 VS FY20
REVENUE : 4654 cr vs 5033 cr ( 7.5% down)
PBT : 220 cr vs 10 cr ( 2100% up)
EPS: 14.31 vs 0.99
OCF: 658 cr VS 626 cr
Q4FY21 & FY21 Numbers
Numbers are ok.Not that Good
QoQ ( Q4FY21 VS Q3FY21 )
REVENUE: 1289 cr vs 1522 cr ( 15% down)
PBT: 75 cr vs 134 cr(79% down)
EPS: 5 vs 8.59
YoY ( Q4FY21 VS Q4FY20)
REVENUE: 1289 cr vs 1318 cr ( 2.2% down)
PBT: 75 cr vs (-1.38) cr(5535% Up)
EPS: 5 vs 0.08
FY21 VS FY20
REVENUE : 4654 cr vs 5033 cr ( 7.5% down)
PBT : 220 cr vs 10 cr ( 2100% up)
EPS: 14.31 vs 0.99
OCF: 658 cr VS 626 cr
SURYA ROSHNI FY21Q4 :
Net Profit Up 96 % to Rs 58.5 cr (YOY)
Revenue Up 29 % to Rs 1722 cr
Net Profit Up 96 % to Rs 58.5 cr (YOY)
Revenue Up 29 % to Rs 1722 cr
LINCOLN PHARMA
Update Q4FY21 & FY21
QoQ ( Q4FY21 VS Q3FY21 )
REVENUE: 82 cr vs 115 cr (28% down)
PBT: 15cr vs 18cr (17% down)
EPS: 6.29 vs 6.74
YoY ( Q4FY21 VS Q4FY20)
REVENUE: 82 cr vs 83 cr (1% down)
PBT: 15cr vs 11.5cr (30% up)
EPS: 6.29 vs 4.47
FY21 VS FY20
REVENUE : 430 cr vs 398 cr (12% up)
PBT : 84 cr vs 67cr (355% up)
EPS: 31.11 vs 25.72
OCF: 69 cr vs 75 cr
Special Note: CO PLANS TO ENTER EU MARKETS IN FY22 WITH DERMATOLOGY, GASTRO & PAIN MANAGEMENT PRODUCTS
Dividend - Rs.1.50 per share
YoY numbers are Good but QOQ its Down.
Update Q4FY21 & FY21
QoQ ( Q4FY21 VS Q3FY21 )
REVENUE: 82 cr vs 115 cr (28% down)
PBT: 15cr vs 18cr (17% down)
EPS: 6.29 vs 6.74
YoY ( Q4FY21 VS Q4FY20)
REVENUE: 82 cr vs 83 cr (1% down)
PBT: 15cr vs 11.5cr (30% up)
EPS: 6.29 vs 4.47
FY21 VS FY20
REVENUE : 430 cr vs 398 cr (12% up)
PBT : 84 cr vs 67cr (355% up)
EPS: 31.11 vs 25.72
OCF: 69 cr vs 75 cr
Special Note: CO PLANS TO ENTER EU MARKETS IN FY22 WITH DERMATOLOGY, GASTRO & PAIN MANAGEMENT PRODUCTS
Dividend - Rs.1.50 per share
YoY numbers are Good but QOQ its Down.
#Thought
Following rules with your emotions against you is the highest sign of discipline.
#Wealthcreatures.com
Following rules with your emotions against you is the highest sign of discipline.
#Wealthcreatures.com
Wealthcreatures.com
ALL I.T PICKS ON RADAR FOR JUNE MONTH RAMCO SYSTEM RESISTANCE @ 580/620 Above that possible New breakout. One can add on dips 540 - 560 zone.Today's Low - 551
525
One can add there
520 is good support
Expecting Good next 1 to 2 Qtrs
Margins improvement can be seen
One can add there
520 is good support
Expecting Good next 1 to 2 Qtrs
Margins improvement can be seen
Wealthcreatures.com
ALLIED DIGITAL CMP - 61 ADD BWT - 58 TO 61 TEST LEVELS # 66/72/75/80++ TF - 1 TO 2 MONTHS S/L - 54 on closing basis or As per Risk
ALLIED DIGITAL
GIVEN YEST
LOCKED 🔒 IN 10% UC
71.40 🎯🎯
GIVEN YEST
LOCKED 🔒 IN 10% UC
71.40 🎯🎯
Lincoln pharma
Ramco system
Valiant organic
All are buy on dips for next 3- 6 - 12 months
Nothing to worry
Just need patience
Follow buying zone & S/L as given
Ramco system
Valiant organic
All are buy on dips for next 3- 6 - 12 months
Nothing to worry
Just need patience
Follow buying zone & S/L as given
Wealthcreatures.com
KPIT TECH 250 FRESH BREAKOUT TRAIL FOR NEXT TEST LEVELS # 275/290/350+++
KPIT TECH
ONE CAN ADD ON DIPS THOSE MISSED.
CMP - 227
GOOD To add on dips bwt 210 - 220 zone
ONE CAN ADD ON DIPS THOSE MISSED.
CMP - 227
GOOD To add on dips bwt 210 - 220 zone
Wealthcreatures.com
KOPRAN 185 Can reverse Strong support@ 170
KOPRAN
KEEP 👀
MOMENTUM CAN SEE ONCE 205-210 IS CROSSED
KEEP 👀
MOMENTUM CAN SEE ONCE 205-210 IS CROSSED
Wealthcreatures.com
LTTS VERY SLOWLY MAKING BASE ABOVE 2610 CAN TEST 2660/2710 NEW ALL TIME HIGH IN NEXT 2 TO 3 MONTHS OR EVEN BEFORE
LTTS
KEEP 👀
2660/2710 LEVELS FOR BREAKOUT & UPMOVE
KEEP 👀
2660/2710 LEVELS FOR BREAKOUT & UPMOVE
We don't play for 2%/5%
We play positional for 20%/30%/50%++ Returns in short to medium Term
Longterm- 1x/2×/5×/10× Returns
We play positional for 20%/30%/50%++ Returns in short to medium Term
Longterm- 1x/2×/5×/10× Returns
Wealthcreatures.com
525 One can add there 520 is good support Expecting Good next 1 to 2 Qtrs Margins improvement can be seen
From Days lows To Days High
573
573
Wealthcreatures.com
Jubilant ingervia Buying opportunity on all dips Lows - 464
Jubilant Ingervia
Blasting 6% 💣💣
503 💚💚
Blasting 6% 💣💣
503 💚💚